Combination therapy with tobevibart and elebsiran potently reduces hepatitis B virus surface antigen levels in preclinical in vivo models. (journals.asm.org)

Authors: Noack J … Lempp FA Journal: Antimicrobial Agents and Chemotherapy Published: 2026-03-04 DOI: https://doi.org/10.1128/aac.01127-25